Odd timing for J&J's proposed takeover of Actelion due to Trump: Pro
Share

Odd timing for J&J's proposed takeover of Actelion due to Trump: Pro

Alex Tarrant, assistant editor at Dealreporter Europe, weighs in on Johnson & Johnson's proposed acquisition of Swiss biotechnology company Actelion.
02:47
Fri, Nov 25 20163:57 AM EST